Stock BLRX BIOLINERX LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Total Return chart BioLineRx Ltd.

Equities

BLRX

IL0011015182

Delayed TEL AVIV STOCK EXCHANGE
Other stock markets
 07:21:31 2024-07-09 am EDT 		5-day change 1st Jan Change
15.1 ILa +2.03% Intraday chart for BioLineRx Ltd. +0.67% -60.47%
May. 30 BioLineRx Ltd Announces Clinical Trial Agreement with St. Jude Children's Research Hospital, Inc. to Evaluate Motixafortide for CD34+ Hematopoietic Stem Cell Mobilization For Gene Therapy Applications in Sickle Cell Disease CI
May. 28 Transcript : BioLineRx Ltd., Q1 2024 Earnings Call, May 28, 2024
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
  1. Stock Market
  2. Equities
  3. BLRX Stock
  4. Charts BioLineRx Ltd.
  5. Total Return chart